Clinuvel Pharmaceuticals Limited (ASX:CUV)

Clinuvel Pharmaceuticals Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 15, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	460	520	770	883	734	1,517
Market Cap Growth	-19.00%	-32.41%	-12.87%	20.40%	-51.63%	19.69%
Enterprise Value	228	323	596	744	636	1,445
Last Close Price	9.13	10.33	15.25	17.69	14.66	30.29
PE Ratio	14.18	14.38	21.60	28.87	35.14	61.34
Forward PE	12.33	13.16	21.49	28.34	26.11	78.02
PS Ratio	4.78	5.48	8.73	11.28	11.16	31.39
PB Ratio	1.85	2.16	3.79	5.37	5.84	15.36
P/TBV Ratio	1.85	2.16	3.80	5.37	5.85	15.39
P/FCF Ratio	11.49	12.75	24.46	24.62	18.61	82.41
P/OCF Ratio	11.38	12.66	20.77	23.93	18.40	78.75
EV/Sales Ratio	2.36	3.40	6.76	9.50	9.68	29.91
EV/EBITDA Ratio	5.17	6.94	12.09	16.71	17.68	49.73
EV/EBIT Ratio	5.30	7.05	12.28	16.86	17.89	50.60
EV/FCF Ratio	5.68	7.91	18.95	20.73	16.13	78.52
Debt / Equity Ratio	0.00	0.00	0.00	0.01	0.01	0.01
Debt / EBITDA Ratio	0.01	0.01	0.02	0.02	0.03	0.04
Debt / FCF Ratio	0.01	0.01	0.03	0.03	0.03	0.07
Net Debt / Equity Ratio	-0.93	-0.93	-0.90	-0.95	-0.96	-0.82
Net Debt / EBITDA Ratio	-5.33	-4.80	-3.71	-3.50	-3.34	-2.80
Net Debt / FCF Ratio	-5.81	-5.48	-5.81	-4.34	-3.05	-4.42
Asset Turnover	0.38	0.38	0.42	0.46	0.52	0.51
Inventory Turnover	1.12	0.87	0.77	1.33	3.69	1.87
Quick Ratio	13.98	9.24	8.33	7.02	10.03	11.35
Current Ratio	14.64	9.66	8.81	7.44	10.24	11.81
Return on Equity (ROE)	13.96%	16.30%	19.39%	21.09%	18.62%	28.95%
Return on Assets (ROA)	10.62%	11.37%	14.29%	16.34%	17.60%	18.78%
Return on Invested Capital (ROIC)	193.72%	172.36%	236.84%	419.57%	190.89%	229.04%
Return on Capital Employed (ROCE)	17.10%	18.70%	23.60%	26.20%	27.30%	28.60%
Earnings Yield	7.07%	6.95%	4.63%	3.46%	2.84%	1.63%
FCF Yield	8.70%	7.84%	4.09%	4.06%	5.38%	1.21%
Dividend Yield	0.53%	0.48%	0.33%	0.28%	0.27%	0.08%
Payout Ratio	7.70%	6.92%	6.93%	6.46%	5.92%	5.00%
Buyback Yield / Dilution	-0.37%	1.27%	1.52%	-0.08%	-1.26%	-1.33%
Total Shareholder Return	0.16%	1.75%	1.85%	0.21%	-0.99%	-1.25%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.